References
- Beutler B, Cerami A. Tumor necrosis factors: the molecules and their emerging role in medicine. New York, NY: Raven Press Limited; 1992.
- Xu Z, Wang Q, Zhuang Y, et al. Subcutaneous bioavailability of golimumab at 3 different injection sites in healthy subjects. J Clin Pharmacol. 2010;50:276–284.
- Scallon BJ, Moore MA, Trinh H, et al. Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions. Cytokine. 1995;7:251–259.
- Shealy D, Cai A, Staquet K, et al. Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α. MAbs. 2010;2(4):428–439.
- European Medicines Agency [internet]. Simponi. Summary of product characteristics; Approval; 2009. Available from: https://www.ema.europa.eu/en/documents/product-information/simponi-epar-product-information_en.pdf
- U.S. Food and Drug Administration [internet]. Simponi. Highlights of prescribing information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125289s146lbl.pdf
- World Medical Association Declaration of Helsinki. Recommendations guiding medical doctors in biomedical research involving human subjects. Ferney-Voltaire, France; 1989 [cited 2007 Aug 17]. Available from: http://fda.gov/oc/health/helsinki89.html
- Handbook for good clinical research practice (GCP) [World Health Organization web site]. Available from: http://www.who.int/medicines/
- Guidelines for bioequivalence studies of generic products. Tokyo, Japan: Pharmaceuticals and Medical Devices Agency; 2015. [cited 2015 Jun 12]. Available from: http://www.pmda.go.jp/files/000157415.pdf
- Ling J, Lyn S, Xu Z, et al. Lack of racial differences in the pharmacokinetics of subcutaneous golimumab in healthy Japanese and caucasian male subjects. J Clin Pharmacol. 2010;50(7):792–802.
- Zhuang Y, Lyn S, Lv Y, et al. Pharmacokinetics and safety of golimumab in healthy Chinese subjects following a single subcutaneous administration in a randomized Phase I trial. Clin Drug Investig. 2013;33:795–800.